AdvanDx develops and markets molecular-based,
in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available within hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations.
More About Us
1.22.2010 | Updates on efforts to improve antibiotic prescribing and patient outcomes via rapid diagnosis of serious infections and sepsis.
12.22.2009 | Faster Results to Help Clinicians Improve Pseudomonal vs. Non-Pseudomonal Antibiotic Selection for Patients with Critical Infections
12.10.2009 | Faster Results to Help Clinicians Improve Antibiotic Selection and Outcomes for Patients with True Staphylococcal Infections while Avoiding...
